Nirto Is Zantac - Search News

GSK settles vast majority of Zantac claims

GSK to Settle 80,000 Zantac Cases for Up to $2.2 Billion

GSK Plc said it will pay as much as $2.2 billion to resolve about 80,000 US court cases related to allegations that its old reflux medication Zantac was contaminated with a suspected carcinogen. The cases represent about 93% of those against the company involving Zantac,

Benzinga.com · 2d

GSK Settles Majority Of Zantac Lawsuits, But Pipeline Doubts Remain

GSK settles 93% of Zantac lawsuits with a $2.2 billion payout, easing investor concerns. However, doubts over its future growth persist as challenges with its drug pipeline remain.

Morningstar · 3d

GSK settles vast majority of Zantac claims for $2.2 billion

GSK has struck a $2.2 billion agreement to settle the vast majority of U.S. lawsuits filed against it over claims its Zantac heartburn remedy causes cancer. The British drugmaker's settlement with ...

Barron's4d

Zantac Maker GSK Agrees To Pay $2.3 Bn In US Settlements

Corrects headline to say 'settlements' instead of 'settlement' British pharmaceutical company GSK said Wednesday it has agreed to pay $2.3 billion in the United States to put an end to lawsuits ...

Reuters4d

GSK agrees to settle about 80,000 Zantac lawsuits for up to $2.2 bln

GSK to pay $70 million to settle whistleblower lawsuit Pfizer and Sanofi also settling Zantac cases Boehringer Ingelheim faces trial, denies wrongdoing Oct 9 (Reuters) - GSK (GSK.L), opens new tab ...

CNN3d

GSK agrees to settle about 80,000 Zantac lawsuits for up to $2.2 billion

GSK has agreed to pay up to $2.2 billion to settle most lawsuits in US state courts claiming that a discontinued version of the heartburn drug Zantac caused cancer, the company announced on ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results